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The second in the new special industry studies in preparation for 
the Georgia Department of Commerce, this analysis points up three major 
advantages which pharmaceutical manufacturers can achieve through a 
Georgia locationo 
Like many of the earlier studies, it points up a combination of a 
large and growing market which can be served more economically in the 
area through the reduction of freight costs, plus lower production costs 
through more efficient operations. 
Additional specifics pertinent to the needs of individual companies 
will be prepared in confidence on requesto 
Comments or questions regarding the study are invited. 
- i-
Kenneth C. Wagner, Chief 
Industrial Development Division 
GEORGIA INSTITUTE OF TECHNOLOGY 
Sununary 
Three factors support the belief that pharmaceutical manufacturers would 
profit appreciably with Georgia branch plants: 
1. Twenty-three percent of the Uo S. market is in an area where 
freight costs would be cheaper from Georgia than from either 
Chicago or New York. 
2o Many plants have grown so large that they are no longer as 
efficient as the smaller ones. 
3. Manufacturing costs would be lower in Georgiao 
There were over $1 billion in retail sales in pharmaceutical products in 
the Georgia freight advantage area (see Map 1), representing over $530 
million at the manufacturers' sales price in 1962o This represents 23% of 
total Uo So sales. Sales of pharmaceuticals for human use in 1967 should be 
37% greater than the 1960 saleso 
In addition, Georgia is recognized as the center of a special market for 
drugs used to treat poultry. Georgia ranks first in broiler production, 
accounting for 18% of the national total. The five-state southeastern areal/ 
is estimated to have $5o7 million in manufacturers' sales annually for 
vaccines for bronchitis and Newcastle diseaseo 
Pharmaceutical production facilities concentrated in the northeastern 
quarter of the U. S. account for 87% of the U. S. production. In contrast, 
the markets are spread over the entire countryo Approximately 42% is pro-
duced outside of the area in which it is consumedo The imbalance between 
production and markets is largest in the South, with 24% of U. So production 
being shipped into the area that accounts for 30% of the U. S. market. 
The northern pharmaceutical plants with over 1,000 employees may find 
after critical examination that their operations would be more productive if 
they establish southern branches. The larger plants, compared with the medium 
size plants in the industry, pay higher wages and realize less value added 
per dollar of payroll, as well as less production per workero 
The national markets can be served from a Georgia plant more economically 
than from an Illinois, New York or California plant. By comparing production 
11 Alabama, Florida, Georgia, North Carolina and South Carolinao 
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labor costs and freight costs between plants located in Atlanta, New York, 
Chicago and Los Angeles, an Atlanta plant would have 11% to 19% higher 
earnings than the other locations. In addition, a Georgia plant would have 
the advantage of lower taxes, lower utility costs and lower construction 
costs. 
With a branch plant in Georgia serving only the southern market, the 
freight savings would be from 37% to 75% of the freight bill at the other 
locations. 
All types of containers and packaging materials are produced in 
Georgia -- glass, plastic, metal, paper, fiber and wood. For many pharma-
ceutical products the container and packaging materials are a major part 
of the shipping weight; thus, another advantage is realized by the economi-
cal source of supply for such packaging materials. 
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INTRODUCTION 
The pharmaceutical preparations industry includes establishments 
primarily engaged in manufacturing, fabricating or processing drugs in pharma-
ceutical preparations for human or veterinary useo Most of the products are 
finished in the form intended for final consumption, such as ampoules, 
tablets, capsules, ointments, medicinal powders, solutions and suspensions. 
Many of the raw materials are procured from basic chemical processorso 
The following pharmaceutical preparations account for more than half 






Vitamins and Hermatinics 
Analgesics 
Total 








This study is concerned with the feasibility of establishing manu-
facturing operations in Georgia to serve either the national or southern 
market. The present and future markets are considered, and a special area 
market for pharmaceuticals used in the poultry industry is explored. In 
pointing out the characteristics of the industry, the concentrated production 
centers and the dispersed regional markets are contrasted, and operating 
characteristics of different size plants are comparedo 
In considering the advantages of having a pharmaceutical plant in 
Georgia, this report concentrates on the labor and freight advantages the 
Georgia plant would haveo Georgia's many other attractions are also 
analyzed: construction costs, natural gas rates, electric rates, property 
taxes, and the availability of containers and other packaging materials. 
-1-
THE MARKET FOR PHARMACEUTICAL PREPARATIONS 
The National Market 
Manufacturers' sales of pharmaceuticals for human use in the United 
States amounted to over $2 billion dollars in 1960ol/ Pharmaceuticals for 
use in treating livestock, poultry and pets accounted for more than $100 
million in manufacturers' sales in the same year. Over the past 12 years 
total sales have grown at an average rate of over 8% a yearol/ 
Ethical sales for human use are made through three types of outlets: 
prescription shops, hospitals and physicians. Overall prescriptions account 
for 60% of the sales, while 21% are sold to hospitals and 19% to physicians. 
However, the sales profile as well as the per capita sales vary between the 
states. A breakdown of these sales by states has been used to estimate the 
markets in the South. 
Manufacturers' sales of pharmaceuticals for human use are expected to 
reach almost $3 billion by 1967 -- a 37% increase over 1960 saleso The fore-
cast is based on a projection of per capita consumption and an authoritative 
forecast of population. Other specialists have forecast a much greater in-
crease in sales, even in excess of 90%o Details are given in Appendix 2o 
Regardless of the forecast used, tremendous growth is predicted for the 
pharmaceutical industry. 
The Southeastern Market 
The southeastern market in this report is the area that a Georgia plant 
can supply at a lower shipping cost than a plant located in Chicago or New 
Yorko Atlanta was used to fix the shipping point in Georgia, and Chicago and 
New York are representative centers for the present producerso The Georgia 
freight advantage area comprises all of seven states and parts of seven 
otherso (See Map 1.) Eleven state~/ were chosen as representative of the 
freight advantage area for purposes of measuring the area's market. 
lf 1960 NWDA Drug Market Data, National Wholesale Druggists' Association. 
]j "Summary of 1960 Sales of Drug Store Products," Drug Topics, 
July 17, 1961. 
3/ Alabama, Arkansas, Florida, Georgia, Kentucky, Louisiana, 






GEORGIA FREIGHT ADVANTAGE AREA 
Industrial Development Division 
Engineering Experiment Station 
GEORGIA INSTITUTE OF TECHNOLOGY 
Motor freight rates are 
lower from Atlanta to 
points in U. S. south of 
line than from Chicago 
or New York 
Manufacturers' total sales in the freight advantage region are estimated 
to be over $530 million in 1962, representing retail sales of more than $1 
billion. In 1960, area sales of pharmaceuticals for human use amounted to 
23% of Uo So sales, or $496 million at the manufacturers' level and $936 
million at the retail level. 
The freight advantage area contained 41.68 million people in 1960, which 
is 23% of the total U. So population. The regional market estimate did not 
involve use of per capita averages but was based on sales in each category 
for each stateo More information is given in Appendix 1. 
For ethical sales, the pattern in the freight advantage area varies from 
the national pattern in that prescriptions have a higher share of the sales 
and physicians purchase less. The following list enables comparison: 
% of Uo s. % of Georgia Freight 
Sales Advantage Area Sales 
Prescription Sales 60o3 62.9 
Hospital and Insti-
tutional Purchases 2lo0 21.1 
Physician Purchases 18o7 16.0 
Total Ethical Sales lOOoO lOOoO 
The 1967 sales estimate for the 11-state freight advantage area is 
almost $680 million at the manufacturers' sales price -- a 37% increase 
over 1960 sales. 
The Wholesale Market 
The southeastern wholesale market is centered in Atlanta, which has a 
total annual wholesaling volume of about $4 billion. This places it $lo5 
billion ahead of its nearest competitor in the Southeast (Memphis). 
In the wholesaling of drugs, drug proprietaries, druggists' sundries, 
and toiletries, Atlanta not only stands fourth in the nation behind New York, 
Chicago and Los Angeles, but it is far ahead of the city that ranks fifth. 
A total of $233 million worth of drugs, drug proprietaries, druggists' 
sundries and toiletries was wholesaled in Atlanta in 1958o The entire New 
England area in the same year wholesaled only $246,900,000, while sales in 
the states of Florida, North Carolina and South Carolina combined were only 
$235,884,000o Twenty-five per cent of all the wholesale sales of these 
-4-
products in the eight South Atlantic states, the District of Columbia, and 
the four East South Central states combined are made in Atlantao 
Special Area Markee!/ 
The large poultry industry in Georgia and the surrounding states pro-
vides a special market for certain pharmaceuticalso Shown below are data 
relating to the quantity of poultry produced in the five-state area of 
Alabama, Florida, Georgia, North Carolina and South Carolina and the area's 









Five-State Area % 
of National Total 
38 
13 
Georgia ranks first in broiler production in the nation, accounting 
for 18% of the national total. 
The standard practice in the poultry industry is to vaccinate every 
day-old chick for bronchitis and Newcastle disease before it leaves the 
hatcheryo In the broiler industry, it is estimated that at least one-half 
of these chicks are re-vaccinated on the farm. It is standard practice for 
all layers to be re-vaccinated on the farm at housing age (16 to 18 weeks)o 
In 1960, the market potential for Georgia was 543,403,000 doses, and the 
five-state area was 1,141,001,000 doseso Assuming a price per dose of Oa5 
cents, manufacturers' sales are estimated to be $2.7 million in Georgia and 
$5a7 million in the five-state area annuallyo 
Pharmaceuticals are also used as feed additives in the poultry industry. 
Based on the standard practice of fortifying feed during the early growing 
period of baby chicks, Georgia's market potential in 1960 for an antibiotic-
1/ Information in this section based on report prepared on pharma-
ceuticals used in the poultry, cattle, and swine industry in Georgia, Alabama, 
Florida, North Carolina and South Carolina by Oliver Terriberry, Industrial 
Development Division, Engineering Experiment Station, Georgia Institute of 
Technology a 
2/ Agricultural Marketing Service Crop Reporting Board, Livestock and 
Poultry Inventory, January, 196lo 
-5-
bacitracin or nitrofuran-type material was 23 pure tons, and the five-state 
area's requirement was 41.7 pure tonsol/ 
By accepted practice, worming materials are used to trea-t broilers once 
during their lives, and layers are treated twice prior to housing and then 
once every 30 days during their laying life of 10 to 14 months. 
The most commonly used materials in worming compounds are piperazine 
salt and phenolthiazine. In 1960, 1,240 tons of piperazine were consumed in 
Georgia, and 3,500 tons were consumed in the five-state area, based on 
16o9% active piperazine salt. Consumption includes material used by the 
livestock industryo 
11 100% concentration basis. Broilers consume seven pounds of feed per 
bird of which 8% is fortified. Layers consume 22 pounds of feed per bird 
during the growing period, of which two pounds are fortified as a standard 
preventive practiceo 
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CHARACTERISTICS OF THE PHARMACEUTICAL PREPARATIONS INDUSTRY 
Location of the Industry and Its Markets 
Almost 87% of the production of pharmaceuticals is concentrated in the 
northern manufacturing belt (Northeastern and East North Central states). 
New York and New Jersey together account for 39% of Do So production, and 
the East North Central states account for 32%. The top producing states 
are listed in Table 1 in descendi~g ordero 
Table 1 
LEADING STATES IN VALUE OF SHIPMENTS FOR PHARMACEUTICAL PREPARATIONS 
. State Percent of U • s. 
New York 24 






Source: United States Census of Manufactures: 1958, U. S. Department of 
Commerce, Bureau of the Census, SIC 2834. 
In contrast, the markets for pharmaceuticals are spread over the entire 
country. Consequently, production locations are out of balance with the 
markets. Approximately 42% of all pharmaceuticals are produced outside of 
the general area where they are consumed. Table 2 and Map 2 show a compari-
son of production and market locations. The largest deficit of production 
is in the South, which imports into the area 24% of the Uo So production in 
order to supply a market amounting to 30% of the total U. S. consumption. 
Plant Size Comparisons in the Industry 
Statistics from the 1958 Census of Manufactures provide a basis for 
comparing the different sizes of establishments in the pharmaceutical 
preparations industry (SIC 2834)o The following study of industry 






COMPARISON OF THE LOCATION OF THE PHARMACEUTICAL INDUSTRY WITH 
THE DISTRIBUTION OF THE MARKETS FOR PHARMACEUTICALS 
SOURCE: 1958 Census of Manufactures. 
The sum of the areas of each 
type circle equals 100%. 
Industrial Development Division 
Engineering Experiment Station 
GEORGIA INSTITUTE OF TECHNOLOGY 
The solid areas represent 
markets and hatched areas 
represent production. 
Table 2 
MEASURE OF BALANCE BETWEEN PRODUCTION AND MARKETS 
FOR PHARMACEUTICALS 
Value of Shipment Consumption 
Area (7o of U. s.~ {7o of Uo 
Northeast 54.39 
East North Central 32.41 
West North Central 4o93 
South 6.01 
West 2o21 
(+) Area manufactures more than it consumeso 














Source: United States Census of Manufactures: 1958, U. s. Department of 
Commerce, Bureau of the Census, SIC 2834. 
each probably would be more productive if operations were decentralized and 
branch plants were located in areas where product consumption is high relative 
to production. 
The establishments of the pharmaceutical preparations industry are 
divided by number of employees into 10 size groupso The smallest has an 
employment range of one to four employees and the largest has 2,500 or more 
employees. The average annual salary paid per employee is compared for the 
different size establishments in Figure 1. This comparison shows that the 
larger the plant, the higher the average annual salary, varying from $3,200 
for the smallest plants to $6,540 for the largest plantso 
When comparing the value added per dollar of payroll for the different 
size establishments, three of the groups stand outo (See Figure 2o) The 
three groups covering plants having between 100 and 1,000 employees show the 
greatest value added per dollar of payroll. The ratios shown on the chart 
indicate that a plant's efficiency apparently declines as plant size grows 
beyond a critical point. 
The ratio of the average production per employee for the group to the 
industry average is compared for the different groups in Figure 3. Again, 
the establishments employing between 100 and 1,000 are outstanding in this 
measure of employee productivity for the industry, exceeding the industry 
average by about 20%. 
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COMPARISON OF STATISTICS FOR THE DIFFERENT SIZE PLANTS 
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Figure 1. Average Annual Salary by 
Size of Establishment. 
INDUSTRY 
AVERAGE 
Figure 2. Value added per Dollar of Payroll 
by Si ze of Establ i shment. 
INDUSTRY 
AVERAGE 
Figure 3. Comparison of the Ratio of Average 
Production per Employee for the 
Group to the Industry Average. 
Figure 4. Average Value of Shipments per 
Establishment by Groups. 
Industrial Development Divis ion 
Eng ineer i ng Experiment Stat ion 
GEORGIA INSTITUTE OF TECHNOLOGY 
SOURCE: Uni ted Sta tes Census of Manufac twe.s : 1958, 
U.S. Department of Commerce, Bureau of the 
Census, SIC 2834. 
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Of the total of 1,114 establishments in 1958, 10.7% accounted for 
90.7% of the value of shipments. The smallest size group, averaging two 
employees per establishment, accounted for 45o2% of the number of establish-
ments but only 0.6% of the value of shipments. (See Figure 4.) 
The location of the medium and large size establishments (100 employees 
and more) is shown by state on Map 3o The 14 largest establishments of 
over 1,000 employees each are located in the six states listed in Table 1 






LOCATION OF THE MEDIUM AND LARGE SIZE PLANTS, ETC. 
SOURCE: 1958 Census of Manufactures 
U.S. Totals, Number of Establishments. 
@ Having 1000 or More Employees 
105 Having 100 to 1000 Employees 
Industria I Development Divis ion 
Engineering Experiment Station 
GEORGIA INSTITUTE OF TECHNOLOGY 
ADVANTAGES OF A GEORGIA LOCATION FOR PRODUCTION FACILITIES 
OF THE PHARMACEUTICAL PREPARATIONS INDUSTRY 
A national manufacturer of pharmaceutical products could more profit-
ably serve either national or southern markets from a plant located in 
Georgia than from established plants in the northern manufacturing belt due 
principally to lower labor costs and advantages to be derived from lower 
transporation costs. 
Labor Costs 
In the pharmaceutical preparations industry (SIC 2834) the average 
production wage in 1958 for the United States was $2.25 per hour. As indi-
cated in Table 3, the average wage by states and regions ranged from a low 
of $1.56 per hour to a high of $2.68 per hour.l/ 
Table 3 
AVERAGE PRODUCTION PAY RATES 
IN THE PHARMACEUTICAL PREPARATIONS INDUSTRY 
FOR STATES AND REGIONsl/ 
Average Pay Rate 
State or Region Per Hour fo of u. So 
Michigan $2o68 119 
Indiana 2o56 114 
East North Central States 2o47 110 
New Jersey 2o35 104 
United States 2.25 100 
Northeast 2.25 100 
Illinois 2o22 99 
New York 2ol9 97 
California 2o06 92 
Ohio 2.04 91 
Missouri lo91 85 
Wisconsin lo87 83 
West North Central States lo86 83 
West South Central States lo75 78 
Texas lo71 76 
North Carolina 1.60 71 
East South Central States 1.59 71 
South Atlantic States lo56 69 
Average 
Source: United States Census of Manufactures: 1958, Uo So Department 
of Commerce, Bureau of the Census, SIC 2834o 
ll States and regions where general statistics are disclosed and that 
have five or more establishments with 20 or more employeeso 
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Although the average wage for Georgia is not revealed, it is approxi-
mately the same as the average for the South Atlantic states, which is $1.56 
per hour or 69% of the Uo So average o Statistics for Georgia have been 
withheld by the Bureau of the Census to avoid disclosing figures for indi-
vidual companieso Georgia had 13 establishments listed under SIC 2834 in 
1958o 
Comparing Georgia with representative locations in the manufacturing 
belt (New York and Illinois) and California, labor savings in Georgia range 
from 24% to 30% of production labor cost. These are: 
When Compared to the 
Average Plant in: 
Production Labor Savings 
for a Georgia Located Plant 
Illinois 30% 
New York 29% 
California 24% 
Freight Costs in Serving the National Market 
Four plant locations were selected for determining the freight bill in 
serving the national market -- Atlanta, New York, Chicago and Los Angeleso 
The destination points for shipments from the plants are the principal cities 
of the 37 wholesale drug areas of the continental United States as defined by 
the National Wholesale Druggists' Associationo By using these areas the 
freight bill could be calculated for the actual sales in each areao The 






Freight Bill as a Percent 





Effect of Labor and Freight Costs on Earnings 
As a result of savings in labor and freight costs, the earnings of an 
Atlanta plant would exceed earnings for plants in the other locations 
being compared by: 
19% over Los Angeles, 
12% over New York and 
11% over Chicagoo 
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These figures are the result of using the averages for the United 
States and determining the influence of wages and shipping costs on earningso 
(See Table 4o) The effect on earnings for the difference in local and state 
taxes, utility costs and construction costs is not included. However, other 
industry studies by the Industrial Development Division of the Georgia Insti-
tute of Technology have evaluated these factors and found that Georgia plants 
have the advantage. 
Table 4 
INFLUENCE OF WAGES AND SHIPPING COSTS ON EARNINGS 
u 0 s. 1/ Georgia New York Illinois California 
Average- (Atlanta) (New York City) (Chicago) (Los Angeles) 
Production 
pay rate: $2o25 hro $1.56 hr. $2.19 hro $2.22 hro $2o06 hro 
Production 
wages as a 
% of plant 
sales: 7.93% 5o 50% 7.72% 7o83% 7.26% 
Shipping 
cost as a 
% of plant 
sales: 1 o 5 7/o lo52% lo67% lo39% 3o34% 
Earnings as 
a % of plant 
sales~ 20.00% 22.48% 20oll% 20.28% 18o90% 
]j Based on 1958 Census of Manufactures. 
Freight Costs in Serving the Southern Market 
Comparing the freight bill for serving the South for plants located in 
Atlanta, New York, Chicago and Los Angeles, freight savings for the Georgia 
plant range from 37% to 75%o Wholesale drug areas were used in defining the 
southern market. These areas do not correspond exactly to the freight ad-
vantage area shown in Map 1. The 10 areas used account for 20% of the Uo So 
sales, while the freight advantage area has 23% of the Uo So sales. The 
effect of this difference is to understate the freight advantages of the 
Georgia planto Freight savings over each location are shown below: 
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When Compared to a 





Freight Savings for a 




The cost advantages of a Georgia plant over present plants are increased 
by the following factors: 
1. Lower capital investment is required for a given production capacity 
in Georgia than in the Northeast. This lowers the amount spent on property 
taxes and increases the per cent return on the investment as well as in-
creases the actual earningso 
Construction costs are proven to be low. Leading contractors are build-
ing plants in the Atlanta area at costs that are 14% to 40% less than con-
struction costs elsewhereo For example, one company recently accepted bids 
for plants built to the same plans at two different locations. The bid in 
Atlanta was $60,000; on a site in New Jersey, the bid was $95,000o Another 
comparison under the same conditions found Atlanta costs 20% lower than 
costs in a central Illinois towno 
Contractors claim the main reason that construction costs are lower in 
Atlanta are climate and worker productivityo There are more working days 
under favorable weather conditionso The attitudes of the workers -- both 
union and non-union -- are superior and permit effective use of new labor-
saving toolso 
2. Natural gas rates in Georgia are 30% to 50% of the rates in the 
New York area. Additional savings are realized because of the milder and 
shorter winters in Georgia. 
3o Electric rates in Georgia are 60% to 80% of the rates in the New 
York areao 
4. Taxes in Georgia are lower than in many other placeso Some specific 
examples are listed in Table 5o 
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Table 5 












Essex County, New Jersey 
Newark, Essex County, N.J. 
Buffalo, Erie County, 
New York 
Cook County, Illinois 
(Chicago Area) 
Wheeling, Ohio County 
West Virginia 







*When comparing not only property taxes, but also West Virginia's Business 
and Occupation Tax and Georgia's Corporate Income Tax and Franchise Tax, 
the Georgia tax bill is 44% of the West Virginia tax billo 
Source: Case studies and files, Industrial Development Division, Georgia 
Institute of Technology. 
11 Georgia property tax bill as a percentage of the tax bill in the 
place being compared, based on equal investment. 
Manufacturers of Containers in Georgia 
Container and box manufacturers in the area are a primary advantage to 
a drug manufacturer. Located in Georgia are plants manufacturing metal, 
plastic and glass containers. These are listed in Table 6o 
In addition, there are many manufacturers of paper fiber and wood con-
tainers located in Georgiao The number of plants are listed by Standard 
Industrial Classification (SIC) in Table 7o 
Containers and packaging materials are a major part of the shipping 
weight of many pharmaceuticals. 
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Table 6 
MANUFACTURERS OF METAL, PLASTIC AND GLASS CONTAINERS IN GEORGIA 
Plant 
American Can Company 
American Can Company 
Crown Cork & Seal 
Company 
Knox Glass Company 

















Oblong cans, beer cans, 
carbonated beverage cans, 
paper tubes with metal ends, 
lithographing facilities 
Coffee cans and other cans 
General open top cans, 
aerosol cans, aluminum 
cans, beer cans, bottle 




High density polyethylene 
bottles 
High and low density 
polyethylene bottles 






















Folding paperboard boxes 
Set-up paperboard boxes 
Corrugated and solid 
fiber boxes 
Sanitary food containers 
Fiber cans, tubes, drums 
and similar products 
Nailed and lock corner 
wooden boxes and shook 
Wirebound boxes and crates 
Veneer and plywood containers, 
except boxes and crates 
Conclusion 
Greater earnings are possible in serving either the national market 
or the southern market when the pharmaceutical items are produced in 
Georgia rather than being produced in the northeastern quarter of the Uo So 
While increased earnings of between 10 and 20 percent can be shown for a 
hypothetical company, the actual increase in earnings that a specific 
company would realize can only be determined from a case study for that 





NATIONAL AND SOUTHERN MARKETS 
The National Wholesale Druggists' Association published the "1960 NWDA 
Drug Market Data" which contains detailed market estimateso Sales in the 
Uo S. and the 11 southern states are shown in Appendix Table 1-A. 
Appendix Table 1-A 
SALES OF PHARMACEUTICALS FOR HUMAN USE 





of U. So 














U. S. Total 















Percent of ethical sales, 
11-state area 
Percent of ethical sales, 















































$ 75.54 $ 57.24 
2lo 11/o 16.00% 
18.67% 
The following information was used in the market calculations. All 
dollars are in millions. 
Proprietaries sales, 1960, U. S. Total: $616.94 
11-state sales estimate using prescription sales percentage: $149ol5 
11-state total of ethical and proprietaries, 1960: $506.93 
Gross margin from manufacturers' to wholesalers' price: 17.16%l/ 
Gross margin from wholesalers' to retail price: 36.00%~/ 
ll Average from August 1962, Lily Digest. 
]j Ibid. 
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Resulting gross mark-up from manufacturers' to 
retail price as percent of manufacturers' price: 
11-state retail sales, 1960: 
Change in retail sales of drugs from 1960 to 1961: 
11-state retail sales, 1961: 
Freight advantage area, Atlanta over Chicago and New York 
Percent of the 11-state population 
Pharmaceutical Preparations Sales: 
88o 6/o 
$956.08 












Livestock, Poultry and Pet Health Aids 
1960 .1 1 
31 
reta~ sa es :-






The retail sales reported by Drug Topics are converted to manufacturers' 
sales dollars by a factor that not only include mark-up but also includes a 
correction in the relative bases between Drug Topics' sales figures and 
NWDA sales figures. The resulting manufacturers' sales dollars in the 
veterinary category can therefore be added to the sales for human use. The 
converting factor is obtained by correlating data between the two sources: 
Drug Topics 1960 retail drug store sales total 
NWDA 1960 drug s.tore sales in manufacturers' dollars~ 




ll Source: Drug Topics Annual Sales Survey. Obtained by combining the 
prescription and packaged medication sales and subtracting the duplicationso 
lf Represents a 3o3% increase over 196lo Percentage increases have 
been greater than this from 1954 through 1961. 
}/ Source: Drug Topics Annual Sales Survey. 
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Appendix 2 
MARKET FORECAST CALCULATIONS 
The growth in annual sales of pharmaceutical products from 1949 to 1961 
is measured by using data published annually by Drug Topicso Three items are 
combined: prescription sales and packaged medication are added, and from 
this the duplication figure is subtracted. The annual sales figure is con-
verted to an index number with 1960 equaling 100. The index is plotted in 
Appendix Figure 2-Ao 
Per capita sales are obtained by dividing annual sales by population 
and then converted to an index with 1960 equaling lOOo This index is 
plotted in Appendix Figure 2-Bo The figures are listed in Appendix Table 2-Ao 
Appendix Table 2-A 
ANNUAL PHARMACEUTICAL SALES DATA 
Change 
from Per Capita 
1/ Previous Sales Index Sales Index 
Year Sales- Year 1960 = 100 Per Capita 1960 == 100 
1961 $3,715,740,000 +3o 4io 103.4 $20o23 101.76 
1960 3,592,550,000 +7 o 7io lOOoO 19.88 100.00 
1959 3,334,620,000 +10 o 9io 93.8 18o81 94o61 
1958 3,007,060,000 +6o2% 83o7 17o28 86.92 
1957 2,830,730,000 +16o8% 78o9 16o53 83.14 
1956 2,423,620,000 +14o9% 67o5 14o41 7lol2 
1955 2,110,010,000 +12o4io 58.7 12o77 64o23 
1954 1,877,230,000 +7 o 2io 52.2 llo56 58ol4 
1953 1,751,150,000 +2 o 4io 48o7 10o97 55.18 
1952 1,710,110,000 +4o6% 47o6 10o89 54o77 
1951 1,634,900,000 +9o4% 45o5 10o59 53o26 
1950 1,494,420,000 +3o 7% 4lo6 9o 85 49o54 
1949 1,441,100,000 40ol 9o66 48o59 
1967 -- from Appendix Figure 2-B $24o50 123o23 
]) The year 1954 and earlier years are adjusted to the same base 






















APPENDIX FIGURE 2-A 
PHARMACEUTICAL SALES INDEX 
APPENDIX FIGURE 2-B 
PER CAPITA SALES INDEX FOR PHARMACEUTICALS 
50 52 54 56 58 60 62 
Industrial Development Division 
Engineering Experiment Station 
GEORGIA INSTITUTE OF TECHNOLOGY 
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64 66 68 70 
The per capita sales for 1967 were estimated, using Appendix Figure 2-Bo 
The sales history for the past 13 years was studied by forecasters of the 
Industrial Development Division who made the estimateo 
The per capita sales figure is multiplied by an authoritative forecast 
1/ 
of population- for 1967 for both the Uo Sa and the 11-state areaa The fore-
cast for 1967 for the Uo So and the 11-state area is 37a28% increase over 
1960a The calculations are shown below~ 
Per capita sales from Appendix Figure 2-B 
















1967 sales index from population index X per capita sales index: 
111.4 x 123.23 = 137.28 or 37.28% increase in 1967 over 1960 
The McGraw-Hill Department of Economics forecast production to increase 
150% by 1975 over 1960. The 1967 production, by using the average rate of 
growth method, would be 54% above 1960a Therefore, for both the production 
and sales forecast to be accurate, substantial price deflation would also 
occura The Wholesale Price Index of Drugs and Pharmaceuticals (Appendix 
Table 2-B) has shown only small variations and actually register deflation 
from 1949 through 1961. 
11 U. Sa News and World Report Population Forecast for 1970o 
11 The 11-state population estimate for 1967 is made from individual 
state estimates and not, as the percentages suggest, by using the same 
percentage of the Uo So as in 1960. 
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Appendix Table 2-B 
WHOLESALE PRICE INDEX OF DRUGS AND PHARMACEUTICALS 














More recently Charles A. Hampton of Abbott Laboratories' Commercial 
1/ Development Division authored a report "Ethical Drugs"- in which he 
forecast an increase of over 90% from 1960 to 1967o The statistical 
technique involved five multiple regression models, providing sophisticated 
forecasting. 
J./ Hampton, Charles Ao, "Ethical Drugs, CW Report," Chemical Week, 
November 17, 1962, p. 134. 
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Appendix 3 
DETERMINATION OF FREIGHT COST 
To determine the freight cost for serving the national market, the 
national market is divided into 37 service area~/ as shown on Appendix 
Map 3-Ao A central city in each area represents the destination of the 
shipments to that area. Appendix Table 3-A shows the area number, the cen-
tral city, and the per cent of U. So sales of ethical drugs in each area. 
The other information needed to calculate the freight bill as a percent 
of sales is the freight rate for each origin-destination pair, and a 
factor for converting dollar sales volume to shipping weighto 
The following mathematical relationships are used: 
~- Service areas's percent of U. S. sales. 
Total 
Total 
S - Dollar volume of the plant sales. 
f - Factor that converts dollar volume sales to hundreds 
of pounds of shipping weight, CWT/$ of sales. 
y - Freight rate to central city in service area. 
B - Freight bill to specific service area. 
B (~) (S) (f) (y) 
B ~lSfyl + ~2Sfy2 + ~3 Sfy3 + etc. 
B Sf(~lyl + ~2y2 + ~3y3 + etco) 
Freight bill as percent of the plant's sales 
Total B 
S = f(~lyl + ~2Y2 + ~3Y3 + etc.) 
The results of the freight calculation are shown in the texto The 
factor for converting sales to shipping weight was picked for convenience 
to be one pound to one dollar of sales. Examination of ratios for some 
actual products displayed a range of from 0.1 pound per dollar of sales to 
six pounds per dollar of sales. Consulting with people in the pharmaceutical 
industry, the $1 per pound average was favored. 
Appendix Table 3-A indicates the service areas that were used to compute 
shipping cost to the freight advantage area. 
1/ Designated wholesale drug areas by the National Wholesale 
Druggists' Association. 
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Appendix Table 3-A 
CENTRAL CITIES FOR SERVICE AREAS 
Area Number Central City Area Percent of u. So 
1 Boston 4.4196 
2 Hartford 1.2727 
3 Albany, N. Yo .9848 
4 New York City 9o7098 
5 Philadelphia 5.2984 
6 Syracuse 2.4470 
7 Pittsburgh 2o3066 
8 Baltimore 2o7020 
9 Richmond~'(' 3o4044 
10 Cincinnati 4.0248 
11 Cleveland 2ol907 
12 Detroit 3o7057 
13 Indianapolis 2.3931 
14 St. Louis 2o6965 
15 Chicago 5.5607 
16 Minneapolis 2.5440 
17 Des Moines 1.4835 
18 Kansas City, Mo. 2o5274 
19 Omaha 1.1768 
20 Denver 1.6922 
21 Butte .4315 
22 Salt Lake City • 7515 
23 Seattle 3.1664 
24 San Francisco 4.5168 
25 Los Angeles 4o5194 
26 El Paso o6381 
27 Dallas* 3o7772 
28 Oklahoma City lo6578 
29 Houston~·.- 2o5769 
30 New Orleans~\- 2.7779 
31 Memphis~·-- 1.5420 
32 Nashville7.- o5790 
33 Birmingham7.- 1.9459 
34 Atlanta~·.- 2.3306 
35 Charlot te'i.- 1.7978 
36 Miami~'.- 2.2885 
37 Milwaukee lo7748 








APPENDIX MAP 3-A 
SERVICE AREAS USED IN FREIGHT COST CALCULATIONS 
Appendix Table 3-A Identifies the 
Central City for Each Area. 
SOURCE: National Wholesale Druggists' Association 
